Evidence map›Paper›PMID 34516252›Full record

ArticleAntimicrobial agents and chemotherapy2021

Long Terminal Repeat Retrotransposon

Mandong Hu, Zongwei Li, Dingchen Li, Jingya Zhao, Yong Chen, Zelei Wang, Fangyan Chen, Li Han

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Divergent sustainability profiles of molnupiravir synthesis routes are governed by solvent use and process design.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Native Joint Infections byDiagnostics (Basel, Switzerland) · 2021
    Review
  6. Spondylodiscitis Caused byDiagnostics (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mandong HuAcademy of Military Medical Sciences, Beijing, People's Republic of China.
Zongwei LiChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Dingchen LiChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Jingya ZhaoChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Yong ChenChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.ORCID 0000-0002-5086-6377
Zelei WangChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Fangyan ChenChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.
Li HanChinese PLA Center for Disease Control and Prevention, Beijing, People's Republic of China.ORCID 0000-0001-9013-8414
Academy of Military Medical Sciences · CN

Funding

National Natural Science Foundation of China (NSFC) 81971914
6 · The paper itself

Abstract

Aspergillus fumigatus causes a series of invasive diseases, including the high-mortality invasive aspergillosis, and has been a serious global health threat because of its increased resistance to the first-line clinical triazoles. We analyzed the whole-genome sequence of 15 A. fumigatus strains from China and found that long terminal repeat retrotransposons (LTR-RTs), including

Indexed as

Aspergillus fumigatusAzolesAntifungal AgentsDrug Resistance, FungalFungal ProteinsMicrobial Sensitivity TestsPhylogenyRetroelementsTerminal Repeat SequencesAntifungal AgentsAzolesFungal ProteinsRetroelementsAfut4Aspergillus fumigatusazole resistancelong terminal repeat retrotransposonsac1

Identifiers

PMID34516252
PMCPMC8597758
OpenAlexW3200313513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.